Gain Therapeutics, Inc.GANXNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank71
3Y CAGR+5.0%
5Y CAGR+34.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+5.0%/yr
vs +78.8%/yr prior
5Y CAGR
+34.1%/yr
Recent deceleration
Acceleration
-73.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$9.79M-9.3%
2024$10.79M-6.3%
2023$11.52M+36.2%
2022$8.46M+15.1%
2021$7.35M+225.3%
2020$2.26M+42.4%
2019$1.59M+91.8%
2018$826880.00-